This study is about testing different forms of a medicine called **Navlimetostat**. It is for healthy adult women to see how the body absorbs and processes the medicine. The study compares two tablet types: one made with wet-granulation and another with dry-granulation. **PK** stands for pharmacokinetics, which means how a drug moves through the body.

**Eligibility:** Participants must be healthy adult females with no significant health issues, a **BMI** (Body Mass Index) between 18.0 and 35.0, and must pass certain health tests for kidneys and liver. **eGFR** is a test for kidney function, and it should be 90 or higher. Tests like **ALP**, **GGT**, **AST**, and **ALT** check liver health and should be within normal limits.

• The study is for healthy adult women only.
• Participants must have certain health tests to join.
• Check with your doctor if you have any medical history that might affect participation.